
Life sciences venture fund backing biotech and biopharma companies from seed to later stage across three regions

A life sciences venture fund investing in biotechnology and biopharma companies across multiple stages

Novartis Venture Fund (NVF) is a venture capital fund that invests in life science companies, with a focus on biotechnology and biopharma. It invests at any stage, from seed to later-stage companies, and takes an active role on the boards of the companies it backs.
NVF invests in biotechnology and biopharma companies across North America, Europe and Israel.
Profile written by TrustList from the business's own published information, Sep 2026.
2 images - click to enlarge
As of 2026-10-13. Organic ranks only; sponsored placements are never ranks.
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Novartis Venture Fund.
Similar listings buyers compare against this one.

Life sciences venture fund backing biotech and biopharma companies from seed to later stage across three regions

An Israeli investment and technology-transfer platform connecting international investors with the country's startup ecosystem

An Africa-focused principal investment and advisory firm putting capital into growing businesses across several sectors

UK lower mid-market private equity group that provided growth capital to fast-growing businesses

Private venture capital firm providing expansion capital and buyout funding to companies in the Southeast and Texas

A family office investing its own capital in real estate, renewable energy and credit
Everything here links back to the same verified catalogue. Pick your next stop.